Fumio Tsuji Selected Research

Fumio Tsuji Research Topics

Disease

7	Arthritis (Polyarthritis) 08/2012 - 03/2002
4	Inflammation (Inflammations) 01/2017 - 01/2010
4	Rheumatoid Arthritis 09/2012 - 07/2008
3	Hypersensitivity (Allergy) 10/2019 - 01/2008
3	Lung Injury 08/2012 - 01/2008
3	Experimental Arthritis 04/2009 - 07/2008
2	Encephalomyelitis (Myeloencephalitis) 08/2012 - 01/2010
2	Autoimmune Diseases (Autoimmune Disease) 08/2012 - 02/2009
2	Hyperalgesia 12/2011 - 11/2010
2	Acute Kidney Injury (Acute Renal Failure) 04/2009 - 05/2008
2	Ischemia 04/2009 - 05/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018
1	Lymphatic Metastasis 04/2018
1	Neoplasm Metastasis (Metastasis) 04/2018
1	Nasal Polyps (Nasal Polyp) 01/2017
1	Rhinosinusitis 01/2017
1	Neoplasms (Cancer) 11/2016
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Uveitis 11/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2012
1	Pain (Aches) 12/2011
1	Chronic Pain 12/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2010
1	Pruritus (Itching) 01/2010
1	Acute Lung Injury 01/2010
1	Splenomegaly 02/2009
1	Respiratory Insufficiency (Respiratory Failure) 01/2008
1	Hamman-Rich Syndrome (Hamman Rich Syndrome) 01/2008
1	Hypoxia (Hypoxemia) 12/2007
1	Hemorrhage 12/2006
1	Asthma (Bronchial Asthma) 10/2006

Drug/Important Bio-Agent (IBA)

6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 03/2002
5	1- (2- (1- adamantyl)ethyl)- 1- pentyl- 3- (3- (4- pyridyl)propyl)ureaIBA 08/2012 - 07/2008
4	CytokinesIBA 08/2010 - 02/2009
3	bucillamine (SA 96)IBA 09/2012 - 09/2009
3	Capsaicin (Zostrix)FDA Link 08/2012 - 05/2008
2	Rheumatoid FactorIBA 09/2012 - 02/2009
2	Urea (Carbamide)FDA LinkGeneric 08/2012 - 04/2009
2	3- acetyl- 6- chloro- 2- (2- (3- (N- (2- ethoxyethyl)- N- isopropylamino)propoxy)- 5- methoxyphenyl)benzothiazoline O,O'-diacetyl-L-tartrateIBA 12/2011 - 11/2010
2	Morphine (MS Contin)FDA LinkGeneric 12/2011 - 11/2010
2	Collagen Type II (Type II Collagen)IBA 08/2010 - 02/2009
2	CollagenIBA 08/2010 - 02/2009
2	LipopolysaccharidesIBA 02/2010 - 01/2010
2	Superoxides (Superoxide)IBA 04/2009 - 05/2008
2	Interleukin-10 (Interleukin 10)IBA 04/2009 - 05/2008
2	Messenger RNA (mRNA)IBA 04/2009 - 05/2008
2	resiniferatoxinIBA 04/2009 - 05/2008
2	Pharmaceutical PreparationsIBA 01/2008 - 10/2006
1	AllergensIBA 10/2019
1	PlatinumIBA 04/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	SteroidsIBA 11/2013
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	NeuropeptidesIBA 08/2012
1	Hypnotics and Sedatives (Sedatives)IBA 12/2011
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 12/2011
1	Analgesics (Analgesic Drugs)IBA 12/2011
1	asimadolineIBA 11/2010
1	Substance PIBA 11/2010
1	AntipruriticsIBA 11/2010
1	Silver NitrateIBA 11/2010
1	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 11/2010
1	AcidsIBA 11/2010
1	Tramadol (K315)FDA LinkGeneric 11/2010
1	Etanercept (Enbrel)FDA Link 08/2010
1	Immunoglobulins (Immunoglobulin)IBA 08/2010
1	OvalbuminIBA 01/2010
1	HydrolasesIBA 01/2010
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2010
1	LeukotrienesIBA 01/2010
1	Interleukin-4 (Interleukin 4)IBA 01/2010
1	Arachidonic Acid (Vitamin F)IBA 01/2010
1	Interleukin-12 Subunit p40IBA 01/2010
1	Leukotriene B4IBA 01/2010
1	AntigensIBA 02/2009
1	Cytokine Receptor gp130IBA 02/2009
1	Interleukin-6 (Interleukin 6)IBA 02/2009
1	Becaplermin (PDGF-BB)FDA Link 02/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	Tyrosine (L-Tyrosine)FDA Link 02/2009
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2009
1	InterleukinsIBA 05/2008
1	TRPV Cation ChannelsIBA 05/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 12/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2007
1	Heparin (Liquaemin)FDA LinkGeneric 12/2006
1	Beclomethasone (Beclometasone)FDA Link 10/2006
1	apaflurane (hydrofluoroalkane)IBA 10/2006

Therapy/Procedure

5	Therapeutics 11/2016 - 12/2006
1	Drug Therapy (Chemotherapy) 04/2018
1	Combination Drug Therapy (Combination Chemotherapy) 04/2018
1	Induction Chemotherapy 04/2018
1	Radiofrequency Ablation 11/2016
1	Radiotherapy 11/2016
1	Ligation 12/2011
1	Aftercare (After-Treatment) 08/2010
1	Nephrectomy 04/2009